|
167 |
|
2023 |
Geography and patient-ascribed ancestry in anti-M hemolytic disease of the fetus and newborn |
Active |
|
|
|
166 |
|
2022 |
WATCH (WearAble Technology for Collecting Health data) on Donors |
Active |
|
|
|
165 |
|
2022 |
Infusion Related Reactions in Cellular Therapy (INR-RCT) |
Active |
|
|
|
164 |
|
2022 |
Home transfusion project: focus groups |
Active |
|
|
|
163 |
|
2021 |
Application of pi-BAT to adverse events at blood transfusion and stem cell infusion |
Active |
|
|
|
162 |
|
2021 |
Clinical Practice Survey of Cryoprecipitate Utilization |
Active |
|
|
|
161 |
|
2021 |
D Alloimmunization bY Trauma? Or Not at All (DAYTONA) |
Completed |
147, 154 |
|
|
160 |
|
2021 |
Assessing the current Demand of ImmunoGlobulins, the "DIG" study |
Active |
|
|
|
159 |
|
2021 |
Is serologic reactivity of unidentified specificity (SRUS) associated with hemolytic disease of the fetus and newborn (HDFN)? |
Completed |
159 |
|
|
158 |
|
2021 |
Comparison of cryoprecipitate production & QC methods |
Active |
|
|